L307-1239 Screening compound: N-[(furan-2-yl)methyl]-3-[4-(morpholine-4-sulfonyl)phenyl]-1,2,4-oxadiazole-5-carboxamide

L307-1239 Screening compound: N-[(furan-2-yl)methyl]-3-[4-(morpholine-4-sulfonyl)phenyl]-1,2,4-oxadiazole-5-carboxamide
L307-1239 Screening compound: N-[(furan-2-yl)methyl]-3-[4-(morpholine-4-sulfonyl)phenyl]-1,2,4-oxadiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L307-1239
N-[(furan-2-yl)methyl]-3-[4-(morpholine-4-sulfonyl)phenyl]-1,2,4-oxadiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L307-1239

Molecular Formula

C18H18N4O6S (C18 H18 N4 O6 S)

Compound Name

N-[(furan-2-yl)methyl]-3-[4-(morpholine-4-sulfonyl)phenyl]-1,2,4-oxadiazole-5-carboxamide

IUPAC name

N-[(furan-2-yl)methyl]-3-[4-(morpholine-4-sulfonyl)phenyl]-124-oxadiazole-5-carboxamide

SMILES

O=C(c1nc(-c(cc2)ccc2S(N2CCOCC2)(=O)=O)no1)NCc1ccco1

InChI

InChI=1S/C18H18N4O6S/c23-17(19-12-14-2-1-9-27-14)18-20-16(21-28-18)13-3-5-15(6-4-13)29(24,25)22-7-10-26-11-8-22/h1-6,9H,7-8,10-12H2,(H,19,23)

InChI Key

YPQKKEJLSPMKDJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27243746

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

418.43

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.116

Distribution Coefficient, logD

2.116

Water Solubility, LogSw

-2.75

Polar Surface Area

103.697

Acid Dissociation Constant (pKa)

11.65

Base Dissociation Constant (pKb)

-5.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

27.80

L307-1239 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

KRAS-Targeted Library (16000 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L307-1239 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L307-1239?
Check Price and Availability of L307-1239, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L307-1239 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L307-1239
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L307-1239
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L307-1239 available by request